Sanofi (SNY) Long-Term Investments (2009 - 2025)

Sanofi (SNY) has 17 years of Long-Term Investments data on file, last reported at $3.8 billion in Q4 2025.

• Quarterly Long-Term Investments rose 1023.45% year-over-year to $3.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.8 billion (up 1023.45% YoY) and the FY2025 annual result came in at $3.8 billion, up 1023.45% from the prior year.
• Long-Term Investments fell to $3.8 billion in Q4 2025 per SNY's latest filing, from $4.0 billion in the prior quarter.
• The five-year high for Long-Term Investments was $4.6 billion in Q2 2023, with the low at $286.0 million in Q4 2021.
• Average Long-Term Investments over 5 years is $2.5 billion, with a median of $3.2 billion recorded in 2024.
• Year-over-year, Long-Term Investments slumped 62.21% in 2021 and jumped 1023.45% in 2025.
• Sanofi's Long-Term Investments stood at $286.0 million in 2021, then surged by 141.51% to $690.7 million in 2022, then plunged by 33.95% to $456.2 million in 2023, then dropped by 25.98% to $337.7 million in 2024, then jumped by 1023.45% to $3.8 billion in 2025.
• Business Quant data shows SNY's Long-Term Investments at $3.8 billion in Q4 2025, $4.0 billion in Q2 2025, and $337.7 million in Q4 2024.